Eli Lilly says 2 drugs lower death rate among high-risk COVID-19 patients

UPI on New Jersey

Jan 27, 2021

Jan. 27 (UPI) -- Drugmaker Eli Lilly says it has an antibody cocktail that has proven to reduce hospitalizations and deaths for high-risk patients with COVID-19, by as much as 70%.